#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15162	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2067	719.8	0	.	n	.	0	C162T	SNP	162	162	C	291	291	T	846	T,C	407,400	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15162	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2067	719.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1313	1313	C	843	C	798	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15162	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2067	719.8	0	HET	.	.	.	C451T	.	451	451	C	580	580	C	843	C,T	426,382	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3523	764.4	0	.	n	.	0	T695C	SNP	695	695	T	1008	1008	C	812	C	765	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3523	764.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	1951	1951	G	873	G,A	417,404	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3523	764.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2284	2284	C	864	C,T	800,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3523	764.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2358	2358	A	844	A	806	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3523	764.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2910	2910	C	862	C	818	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2106	folP	855	855	100.0	folP.l15.c4.ctg.1	1686	124.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1120	1122	AGC	224;229;232	A,G;G;C	212,1;218;220	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4718	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3521	133.5	1	SNP	p	S91F	1	.	.	271	273	TTC	648	650	TTC	160;160;160	T;T;C	153;152;151	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4718	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3521	133.5	1	SNP	p	D95G	1	.	.	283	285	GGC	660	662	GGC	159;158;157	G;G;C	149;148;147	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4718	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3521	133.5	1	SNP	p	G95N	0	.	.	283	285	GGC	660	662	GGC	159;158;157	G;G;C	149;148;147	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1736	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1421	121.7	1	SNP	p	G45D	0	.	.	133	135	GGC	475	477	GGC	230;227;224	G;G;C	217;215;212	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	852	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1104	77.0	0	.	n	.	0	A197.	DEL	197	197	A	602	602	A	201	A	188	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4976	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	166.2	1	SNP	p	D86N	0	.	.	256	258	GAC	636	638	GAC	182;179;177	G;A;C	172;164;167	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4976	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	166.2	1	SNP	p	S87R	1	.	.	259	261	CGT	639	641	CGT	179;179;179	C;G;T	168;168;169	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4976	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	166.2	1	SNP	p	R87W	0	.	.	259	261	CGT	639	641	CGT	179;179;179	C;G;T	168;168;169	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4976	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	166.2	1	SNP	p	R87I	0	.	.	259	261	CGT	639	641	CGT	179;179;179	C;G;T	168;168;169	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4976	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	166.2	1	SNP	p	S88P	0	.	.	262	264	TCC	642	644	TCC	177;180;184	T;C;C	168;171;176	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4286	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2620	162.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1482	1484	GGC	205;206;205	G;G;C	190;192;187	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1289	1291	GCC	203;201;199	G;C;C	193;193;190	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1292	1294	ATG	201;200;201	A;T;G	193;192;192	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1304	1306	ACC	198;196;200	A;C;C	187;188;190	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1304	1306	ACC	198;196;200	A;C;C	187;188;190	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1805	1807	ACC	220;222;222	A;C;C	197;202;204	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1859	1861	GCG	232;235;237	G;C;G	222;226;226	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1859	1861	GCG	232;235;237	G;C;G	222;226;226	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1982	1984	GGT	175;173;170	G;G;T,C	166;165;157,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1991	1993	AGC	159;159;160	A;G;C	151;152;154	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4164	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2430	170.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2009	2011	CCG	137;135;137	C,G;C,G;G	104,8;102,1;109	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5674	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	2892	194.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1558	1560	CCG	203;204;205	C;C;G	180;189;179	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2178	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1829	118.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	535	535	C	166	C	155	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3020	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1357	219.0	1	SNP	p	G120K	1	.	.	358	360	AAG	535	537	AAG	269;267;270	A;A;G	256;254;255	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3020	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1357	219.0	1	SNP	p	A121N	1	.	.	361	363	AAC	538	540	AAC	271;273;272	A;A;C,A	258;263;260,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3020	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1357	219.0	1	SNP	p	N121D	0	.	.	361	363	AAC	538	540	AAC	271;273;272	A;A;C,A	258;263;260,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11356	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4879	232.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1246	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1023	121.4	1	SNP	p	V57M	1	.	.	169	171	ATG	498	500	ATG	256;262;265	A;T;G	240;246;250	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
